OpZira
Middletown, US · Founded 2025 · Delaware corporation · 2 known investors
OpZira develops wearable and diagnostic testing systems for the detection and monitoring of retinal and visual pathway diseases. The company serves eye care professionals and healthcare providers working with patients at risk for or diagnosed with ocular conditions.
Founders & leadership
CE
Clark E. TedfordPresident and CEO
Board
YY
Yigang YangBoard director
JS
Jackson StreeterBoard director
Investors · 2
Also in the syndicate · 1
WaterStar Capital
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 of 2 rounds · 2025–2026
▶$1.1MraisedMar 2026 · 6 investors · Other TechnologyRule 506(b)
▶$1.1MraisedMar 2026 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yigang YangDirector
- Jackson StreeterDirector
- Clark TedfordExecutive Officer, Director
- Amount sold
- $1.1M
- Minimum investment
- $50K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does OpZira do?
- OpZira develops wearable and diagnostic testing systems for the detection and monitoring of retinal and visual pathway diseases. The company serves eye care professionals and healthcare providers working with patients at risk for or diagnosed with ocular conditions.
- Who are OpZira's investors?
- OpZira's investors include NW Angel.
- How much funding has OpZira raised?
- OpZira has disclosed $1.1M raised across 1 of its 2 known rounds.
- Where is OpZira headquartered?
- OpZira is headquartered in Middletown, US.